DNLI
Price
$20.47
Change
+$0.75 (+3.80%)
Updated
Sep 21 closing price
Capitalization
3.15B
50 days until earnings call
Intraday BUY SELL Signals
MCRB
Price
$4.07
Change
+$0.07 (+1.75%)
Updated
Sep 21 closing price
Capitalization
40.18M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNLI vs MCRB

DNLI vs MCRB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DNLI vs. MCRB commentary
Sep 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and MCRB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.15B) has a higher market cap than MCRB($40.2M). DNLI has higher P/E ratio than MCRB: DNLI (62.89) vs MCRB (12.22). DNLI YTD gains are higher at: 23.985 vs. MCRB (-72.648). MCRB has higher annual earnings (EBITDA): 24.9M vs. DNLI (-526.81M). DNLI has more cash in the bank: 710M vs. MCRB (15.6M). DNLI has less debt than MCRB: DNLI (32.2M) vs MCRB (56.6M). DNLI has higher revenues than MCRB: DNLI (3.6M) vs MCRB (1.88M).
DNLIMCRBDNLI / MCRB
Capitalization3.15B40.2M7,841%
EBITDA-526.81M24.9M-2,116%
Gain YTD23.985-72.648-33%
P/E Ratio62.8912.22515%
Revenue3.6M1.88M191%
Total Cash710M15.6M4,551%
Total Debt32.2M56.6M57%
FUNDAMENTALS RATINGS
DNLI vs MCRB: Fundamental Ratings
DNLI
MCRB
OUTLOOK RATING
1..100
5169
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6289
P/E GROWTH RATING
1..100
9960
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCRB's Valuation (67) in the Biotechnology industry is in the same range as DNLI (90). This means that MCRB’s stock grew similarly to DNLI’s over the last 12 months.

MCRB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DNLI (100). This means that MCRB’s stock grew similarly to DNLI’s over the last 12 months.

MCRB's SMR Rating (98) in the Biotechnology industry is in the same range as DNLI (98). This means that MCRB’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's Price Growth Rating (62) in the Biotechnology industry is in the same range as MCRB (89). This means that DNLI’s stock grew similarly to MCRB’s over the last 12 months.

MCRB's P/E Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for DNLI (99). This means that MCRB’s stock grew somewhat faster than DNLI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLIMCRB
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Sep 22, 2026
Stock price -- (DNLI: $20.47 vs. MCRB: $4.07)
Brand notoriety: DNLI and MCRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 193% vs. MCRB: 59%
Market capitalization -- DNLI: $3.15B vs. MCRB: $40.18M
DNLI [@Biotechnology] is valued at $3.15B. MCRB’s [@Biotechnology] market capitalization is $40.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $128.84B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green while MCRB’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • MCRB’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNLI and MCRB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while MCRB’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 6 bearish.
  • MCRB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, MCRB is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -3.53% price change this week, while MCRB (@Biotechnology) price change was -13.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.13%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was +5.00%.

Reported Earning Dates

DNLI is expected to report earnings on Nov 11, 2026.

MCRB is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNLI
Daily Signal:
Gain/Loss:
MCRB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ISBG17.201.00
+6.17%
Incomestkd 1X Bitcoin & 1X Gold Premium ETF
OVB19.970.13
+0.66%
Overlay Shares Core Bond ETF (OVB)
HYMB24.150.02
+0.08%
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF (HYMB)
KCSH25.08N/A
N/A
KraneShares Sustainable Ultra Short Duration Index ETF (KCSH)
IIM11.97-0.02
-0.17%
INVESCO VALUE Municipal Income TRUST

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with VIR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+3.80%
VIR - DNLI
52%
Loosely correlated
+2.64%
VCYT - DNLI
50%
Loosely correlated
+4.33%
EDIT - DNLI
50%
Loosely correlated
+4.81%
BCYC - DNLI
49%
Loosely correlated
-0.55%
PCVX - DNLI
47%
Loosely correlated
+1.36%
More